Аутоиммунные заболевания и дисфункция щитовидной железы при ревматоидном артрите

Автор: Кондратьева Л.В., Попкова Т.В.

Журнал: Научно-практическая ревматология @journal-rsp

Рубрика: Обзоры

Статья в выпуске: 2 т.55, 2017 года.

Бесплатный доступ

В обзоре литературы рассматриваются различные аспекты сочетания ревматоидного артрита (РА) с аутоиммунными заболеваниями щитовидной железы (тиреоидитом Хашимото и болезнью Грейвса). Обсуждаются распространенность, генетическая предрасположенность, сходство патогенеза и клинических симптомов, а также способность органоспецифичных аутоантител (антител к тиреоидной пероксидазе, антител к тиреоглобулину) и гипотиреоза влиять на течение РА и риск кардиоваскулярых осложнений.

Ревматоидный артрит, аутоиммунные заболевания щитовидной железы, тиреоидит хашимото, болезнь грейвса, антитела к тиреоглобулину, антитела к тиреоидной пероксидазе, гипотиреоз, кардиоваскулярные заболевания

Короткий адрес: https://readera.org/14945811

IDR: 14945811   |   DOI: 10.14412/1995-4484-2017-211-217

Список литературы Аутоиммунные заболевания и дисфункция щитовидной железы при ревматоидном артрите

  • Насонов ЕЛ, редактор. Ревматология. Клинические рекомендации. Москва: ГЭОТАР-Медиа; 2010
  • Александрова ЕН, Авдеева АС, Лукина ГВидр. Клиникоиммунологические эффекты анти-В-клеточной терапии у больных ревматоидным артритом. Научно-практическая ревматология. 2012; 50(1): 14-21
  • Авдеева АС, Новиков АА, Александрова ЕНидр. Связь уровней цитокинов с активностью заболевания, уровнем аутоантител и деструктивными изменениями суставов при раннем ревматоидном артрите. Научно-практическая ревматология. 2015; 53(4): 385-90
  • Duraes C, Moreira CS, Alvelos I, et al. Genetic susceptibility to autoimmune tbyroid disease: past, present, and future. Thyroid. 2010 Jul; 20(7): 715-25 DOI: 10.1089/thy.2010.1644
  • Barton A, Wortbington J. Genetic susceptihility to rheumatoid arthritis: an emerging picture. Arthritis Rheum. 2009 Oct 15; 61(10): 1441-6 DOI: 10.1002/art.24672
  • Tomer Y, Huber A. The etiology of autoimmune thyroid disease: a story of genes and environment. J Autoimmun. 2009 May-Jun; 32(3-4): 231-9 DOI: 10.1016/j.jaut.2009.02.007
  • Kä llberg H, Ding B, Padyukov L, et al. EIRA Study Group. Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke. Ann Rheum Dis. 2011 Mar; 70(3): 508-11 DOI: 10.1136/ard.2009.120899
  • Dayan CM, Daniels GH. Chronic autoimmune thyroiditis. N Engl J Med. 1996 Jul 11; 335(2): 99-107 DOI: 10.1056/NEJM199607113350206
  • Ngo SX, Steyn FJ, McCombe PA. Gender differences in autoimmune disease. Front Neuroendocrinol. 2014 Aug; 35(3): 347-69. Научно-практическая ревматология. 2017; 55(2): 211-217 DOI: 10.1016/j.yfrne.2014.04.004
  • Heuer M, Aust G, Ode-Hakim S, Scherbaum WA. Different cytokine mRNA profiles in Graves' disease, Hashimoto's thyroiditis, and nonautoimmune thyroid disorders determined by quantitative reverse transcriptase polymerase chain reaction (RT-PCR). Thyroid. 1996 Apr; 6(2): 97-106 DOI: 10.1089/thy.1996.6.97
  • Nanba T, Watanabe M, Inoue N, Iwatani Y. Increases of the Th1/Th2 cell ratio in severe Hashimoto's disease and in the proportion of Th17 cells in intractable Graves' disease. Thyroid. 2009 May; 19(5): 495-501 DOI: 10.1089/thy.2008.0423
  • Giordano C, Richiusa P, Bagnasco M, et al. Differential regulation of Fas-mediated apoptosis in both thyrocyte and lymphocyte cellular compartments correlates with opposite phenotypic manifestations of autoimmune thyroid disease. Thyroid. 2001 Mar; 11(3): 233-44 DOI: 10.1089/105072501750159615
  • Ajjan RA, Watson PF, McIntosh RS, Weetman AP. Intrathyroidal cytokine gene expression in Hashimoto's thyroiditis. Clin Exp Immunol. 1996 Sep; 105(3): 523-8 DOI: 10.1046/j.1365-2249.1996.d01-784.x
  • Gianoukakis AG, Khadavi N, Smith TJ. Cytokines, Graves' disease, and thyroid-associated ophthalmopathy. Thyroid. 2008 Sep; 18(9): 953-8 DOI: 10.1089/thy.2007.0405
  • Helen Kemp E, Ajjan RA, Metcalfe RA, et al. IL-14 and IL-16 are expressed in the thyroid of patients with either Graves' disease or Hashimoto's thyroiditis. Clin Endocrinol (Oxford). 2015 May 4 DOI: 10.1111/cen.12810
  • Ajjan RA, Weetman AP. Cytokines in thyroid Autoimmunity. Autoimmunity. 2003 Sep-Nov; 36(6-7): 351-9 DOI: 10.1080/08916930310001603046
  • Mikos H, Mikos M, Obara-Moszynska M, Niedziela M. The role of the immune system and cytokines involved in the pathogenesis of autoimmune thyroid disease (AITD). Endokrynol Pol. 2014; 65(2): 150-5 DOI: 10.5603/EP.2014.0021
  • Segni M, Pucarelli I, Truglia S, et al. High prevalence of anti-nuclear anti-bodies in children with thyroid autoimmunity. J Immunol Res. 2014; 2014: 150239 DOI: 0.1155/2014/150239
  • Tagoe CE, Zezon A, Khattri S, Castellanos P. Rheumatic manifestations of euthyroid, anti-thyroid antibody-positive patients. RheumatolInt. 2013 Jul; 33(7): 1745-52 DOI: 10.1007/s00296-012-2616-9
  • Tektonidou MG, Anapliotou M, Vlachoyiannopoulos P, Moutsopoulos HM. Presence of systemic autoimmune disorders in patients with autoimmune thyroid diseases. Ann Rheum Dis. 2004 Sep; 63(9): 1159-61 DOI: 10.1136/ard.2004.022624
  • Perez-Moreiras JV, Alvarez-Lopez A, Gomez EC. Treatment of active corticosteroid-resistant Graves' orbitopathy. Ophthal Plast Reconstr Surg. 2014 Mar-Apr; 30(2): 162-7 DOI: 10.1097/IOP.0000000000000037
  • Salvi M. Immunotherapy for Graves' ophthalmopathy. Curr Opin Endocrinol Diabetes Obes. 2014 Oct; 21(5): 409-14 DOI: 10.1097/MED.0000000000000097
  • Figueroa-Vega N, Alfonso-Perez M, Benedicto I, et al. Increased circulating pro-inflammatory cytokines and Th17 lymphocytes in Hashimoto's thyroiditis. J Clin Endocrinol Metab. 2010 Feb; 95(2): 953-62 DOI: 10.1210/jc.2009-1719
  • Ruggeri RM, Saitta S, Cristani M, et al. Serum interleukin-23 (IL-23) is increased in Hashimoto's thyroiditis. Endocr J. 2014; 61(4): 359-63 DOI: 10.1507/endocrj.EJ13-0484
  • Насонов ЕЛ, Александрова ЕН, Новиков АА. Аутоиммунные ревматические заболевания: итоги и перспективы научных исследований. Научно-практическая ревматология. 2015; 53(3): 230-7
  • Nakano A, Watanabe M, Iida T, et al. Apoptosis-induced decrease of intrathyroidal CD4(+)CD25(+) regulatory T cells in autoimmune thyroid diseases. Thyroid. 2007 Jan; 17(1): 25-31 DOI: 10.1089/thy.2006.0231
  • Vanderpump MPJ, Tunbridge WMG, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey. Clin Endocrinol. 1995; 43(1): 55-68 DOI: 10.1111/j.1365-2265.1995.tb01894.x
  • Cardenas Roldan J, Amaya-Amaya J, Castellanos-de la Hoz J, et al. Autoimmune thyroid disease in rheumatoid arthritis: a global perspective. Arthritis. 2012; 2012: 864907 DOI: 10.1155/2012/864907
  • Atzeni F, Doria A, Ghirardello A, et al. Anti-thyroid antibodies and thyroid dysfunction in rheumatoid arthritis: prevalence and clinical value. Autoimmunity. 2008 Feb; 41(1): 111-5 DOI: 10.1080/08916930701620100
  • El-Sherif WT, El Gendi SS, Ashmawy MM, et al. Thyroid disorders and autoantibodies in systemic lupus erythematosus and rheumatoid arthritis patients. Egypt J Immunol. 2004; 11(2): 81-90.
  • Przygodzka M, Filipowicz-Sosnowska A. Prevalence of thyroid diseases and antithyroid antibodies in women with rheumatoid arthritis. Pol Arch Med Wewn. 2009 Jan-Feb; 119(1-2): 39-43.
  • Raterman HG, Jamnitski A, Lems WF, et al. Improvement of thyroid function in hypothyroid patients with rheumatoid arthritis after 6 months of adalimumab treatment: a pilot study. J Rheumatol. 2011 Feb; 38(2): 247-51 DOI: 10.3899/jrheum.100488
  • Pan XF, Gu JQ, Shan ZY. Increased risk of thyroid autoimmunity in rheumatoid arthritis: a systematic review and metaanalysis. Endocrine. 2015 Sep; 50(1): 79-86 DOI: 10.1007/s12020-015-0533-x
  • Shiroky JB, Cohen M, Ballachey ML, Neville C. Thyroid dysfunction in rheumatoid arthritis: a controlled prospective survey. Ann Rheum Dis. 1993 Jun; 52(6): 454-6 DOI: 10.1136/ard.52.6.454
  • McCoy SS, Crowson CS, Gabriel SE, Matteson EL. Hypothyroidism as a risk factor for development of cardiovascular disease in patients with rheumatoid arthritis. J Rheumatol. 2012 May; 39(5): 954-8 DOI: 10.3899/jrheum.111076
  • Парамонова ОВ, Русанова ОА, Гонтарь ИП. Взаимосвязь органоспецифической аутоиммунной патологии щитовидной железы с неорганическими аутоиммунными ревматическими заболеваниями. Клиническая и экспериментальная тиреоидология. 2012; 8(1): 46-50
  • Delamere JP, Scott DL, Felix-Davies DD. Thyroid dysfunction and rheumatic diseases. J R Soc Med. 1982 Feb; 75(2): 102-6.
  • Boelaert K, Newby PR, Simmonds MJ, et al. Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. Am J Med. 2010 Feb; 123(2): 183.e1-9 DOI: 10.1016/j.amjmed.2009.06.030
  • Andonopoulos AP, Siambi V, Makri M, et al. Thyroid function and immune profile in rheumatoid arthritis. A controlled study. Clin Rheumatol. 1996 Nov; 15(6): 599-603 DOI: 10.1007/BF02238551
  • Chan AT, Al-Saffar Z, Bucknall RC. Thyroid disease in systemic lupus erythematosus and rheumatoid arthritis. Rheumatology (Oxford). 2001 Mar; 40(3): 353-4 DOI: 10.1093/rheumatology/40.3.353
  • Al-Awadhi AM, Olusi S, Hasan EA, Abdullah A. Frequency of abnormal thyroid function tests in Kuwaiti Arabs with autoimmune diseases. Med Princ Pract. 2008; 17(1): 61-5 DOI: 10.1159/000109592
  • Raterman HG, van Halm VP, Voskuyl AE, et al. Rheumatoid arthritis is associated with a high prevalence of hypothyroidism that amplifies its cardiovascular risk. Ann Rheum Dis. 2008 Feb; 67(2): 229-32 DOI: 10.1136/ard.2006.068130
  • Santos MJ, Vinagre F, Silva JJ, et al. Cardiovascular risk profile in systemic lupus erythematosus and rheumatoid arthritis: a comparative study of female patients. Acta Reumatol Port. 2010 Jul-Sep; 35(3): 325-32.
  • Kerola AM, Nieminen TV, Kauppi MJ, et al. Increased risk of levothyroxine-treated hypothyroidism preceding the diagnosis of rheumatoid arthritis: a nationwide registry study. Clin Exp Rheumatol. 2014 Jul-Aug; 32(4): 455-9.
  • Bengtsson C, Padyukov L, Källberg H, Saevarsdottir S. Thyroxin substitution and the risk of developing rheumatoid arthritis; results from the Swedish population-based EIRA study. Ann Rheum Dis. 2014 Jun; 73(6): 1096-100 DOI: 10.1136/annrheumdis-2013-203354
  • Никитина НМ, Афанасьев ИА, Романова ТА, Ребров АП. Особенности коморбидности у больных ревматоидным артритом в разные годы наблюдения. Современная ревматология. 2015; 9(1): 39-43.
  • LeRiche NGH, Bell DA. Hashimoto's thyroiditis and polyarthritis: a possible subset of seronegative polyarthritis. Ann Rheum Dis. 1984 Aug; 43(4): 594-8 DOI: 10.1136/ard.43.4.594
  • Punzi L, Michelotto M, Pianon M, et al. Clinical, laboratory and immunogenetic aspects of arthritis associated with chronic lymphocytic thyroiditis. Clin Exp Rheumatol. 1997 Jul-Aug; 15(4): 373-80.
  • Blake DR, McGregor AM, Stansfield E, Smith BR. Antithyroid-antibody activity in the snyovial fluid of patients with various arthritides. Lancet. 1979 Aug 4; 2(8136): 224-6 DOI: 10.1016/S0140-6736(79)90238-1
  • Punzi L, Schiavon F, Ramonda R, et al. Anti-thyroid microsomal antibody in synovial fluid as a revealing feature of seronegative autoimmune thyroiditis. Clin Rheumatol. 1991 Jun; 10(2): 181-3 DOI: 10.1007/BF02207661
  • Bourji K, Gatto M, Cozzi F, et al. Rheumatic and autoimmune thyroid disorders: a causal or casual relationship? Autoimmun Rev. 2015 Jan; 14(1): 57-63 DOI: 10.1016/j.autrev.2014.10.007
  • Hezarkhani S, Sedighi S, Aghaei M, et al. Rheumatologic manifestations in Iranian patients with autoimmune thyroid diseases. J Clin Diagn Res. 2014 0ct; 8(10): MC06-8 DOI: 10.7860/JCDR/2014/7974.4981
  • Punzi L, Sfriso P, Pianon M, et al. Clinical manifestations and outcome of polyarthralgia associated with chronic lymphocytic thyroiditis. Semin Arthritis Rheum. 2002 Aug; 32(1): 51-5 DOI: 10.1053/sarh.2002.33722
  • Ahmad J, Blumen H, Tagoe CE. Association of antithyroid peroxidase antibody with fibromyalgia in rheumatoid arthritis. Rheumatol Int. 2015 Aug; 35(8): 1415-21 DOI: 10.1007/s00296-015-3278-1
  • Серебряков ВГ, Алекберова ЗС, Корешков ГГ, Зеновко ЕИ. Особенности течения ревматоидного артрита, сочетающегося с патологией щитовидной железы. Терапевтический архив. 1990; 62(5): 48-51.
  • Koszarny A, Majdan M, Suszek D, et al. Relationship between rheumatoid arthritis activity and antithyroid antibodies. Pol Arch Med Wewn. 2013; 123(7-8): 394-400.
  • Raterman HG, Voskuyl AE, Simsek S, et al. Increased progression of carotid intima media thickness in thyroid peroxidase antibod-ies-positive rheumatoid arthritis patients. Eur J Endocrinol. 2013 Oct 21; 169(6): 751-7 DOI: 10.1530/EJE-13-0394
  • Dessein PH, Joffe BI, Stanwix AE. Subclinical hypothyroidism is associated with insulin resistance in rheumatoid arthritis. Thyroid. 2004 Jun; 14(6): 443-6 DOI: 10.1089/105072504323150750
  • Raterman HG, van Eijk IC, Voskuyl AE, et al. The metabolic syndrome is amplified in hypothyroid rheumatoid arthritis patients: a cross-sectional study. Ann Rheum Dis. 2010 Jan; 69(1): 39-42 DOI: 10.1136/ard.2008.100776
  • Dessein PH, Joffe BI, Veller MG, et al. Traditional and nontradi-tional cardiovascular risk factors are associated with atherosclerosis in rheumatoid arthritis. J Rheumatol. 2005 Mar; 32(3): 435-42.
  • Dessein PH, Norton GR, Woodiwiss AJ, et al. Influence of non-classical cardiovascular risk factors on the accuracy of predicting subclinical atherosclerosis in rheumatoid arthritis. J Rheumatol. 2007 May; 34(5): 943-51.
  • Marchiori RC, Pereira LA, Naujorks AA, et al. Improvement of blood inflammatory marker levels in patients with hypothyroidism under levothyroxine treatment. BMC Endocr Disord. 2015 Jun 23; 15: 32 DOI: 10.1186/s12902-015-0032-3
Еще
Статья научная